Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Biorestorative Therapies Inc's Business Segments
Biorestorative Therapies Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
Product
Total Revenue
$ 0
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Product41.4%
- Royalty39.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 0 | 41.4% |
| Royalty | $ 0 | 39.4% |
Revenue by Product & Service Category - FY
- Product41.9%
- Royalty38.4%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 0 | 41.9% |
| Royalty | $ 0 | 38.4% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Product41.4%
- Royalty39.4%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 0 | 41.4% |
| Royalty | $ 0 | 39.4% |
Description of Biorestorative Therapies Inc
Biorestorative Therapies Inc. is a biotechnology company that focuses on the development of medical procedures using cell-based therapies. The company specializes in developing therapies to treat various diseases and conditions by utilizing the body's own natural repair mechanisms.
Biorestorative Therapies Inc. was founded in 2011 and is headquartered in New York. The company's primary focus is on developing and commercializing stem cell-based therapies to restore function and repair damaged tissues and organs.
The main area of focus for Biorestorative Therapies Inc. is regenerative medicine. Regenerative medicine is a branch of medicine that aims to restore or replace damaged or diseased tissues and organs. The company is utilizing advanced technologies to harness the power of stem cells and other cell-based therapies to achieve these goals.
One of the key products being developed by Biorestorative Therapies Inc. is the ThermoStem program. ThermoStem is a treatment that uses a patient's own adipose (fat) derived stem cells to regenerate thermal burn injuries. This program is in the pre-clinical stage and has shown promising results in preclinical studies.
Another important program under development by Biorestorative Therapies Inc. is the brown fat program. Brown fat is a type of fat that burns calories to generate heat, and its activation has the potential to combat obesity and metabolic disorders. The company is working on developing a method to increase the amount of brown fat in the body, which could have significant therapeutic implications.
In addition to these programs, Biorestorative Therapies Inc. is also involved in the development of cell-based therapies for various other conditions like disc degeneration in the spine, metabolic disorders, and age-related muscle loss.
The company is actively engaged in research and development activities to advance its therapies through preclinical and clinical studies. Biorestorative Therapies Inc. works closely with leading scientists, researchers, and medical institutions to further its understanding and application of regenerative medicine.
Furthermore, the company has a strong commitment to regulatory compliance and ensures that its therapies are developed and tested in accordance with the highest safety and quality standards. Biorestorative Therapies Inc. aims to obtain regulatory approvals for its therapies and eventually make them available to patients worldwide.
Overall, Biorestorative Therapies Inc. is a biotechnology company dedicated to the development of innovative cell-based therapies to address a wide range of medical conditions. With a focus on regenerative medicine, the company aims to restore function and improve the quality of life for patients through the use of advanced stem cell technologies.
Biorestorative Therapies Inc. was founded in 2011 and is headquartered in New York. The company's primary focus is on developing and commercializing stem cell-based therapies to restore function and repair damaged tissues and organs.
The main area of focus for Biorestorative Therapies Inc. is regenerative medicine. Regenerative medicine is a branch of medicine that aims to restore or replace damaged or diseased tissues and organs. The company is utilizing advanced technologies to harness the power of stem cells and other cell-based therapies to achieve these goals.
One of the key products being developed by Biorestorative Therapies Inc. is the ThermoStem program. ThermoStem is a treatment that uses a patient's own adipose (fat) derived stem cells to regenerate thermal burn injuries. This program is in the pre-clinical stage and has shown promising results in preclinical studies.
Another important program under development by Biorestorative Therapies Inc. is the brown fat program. Brown fat is a type of fat that burns calories to generate heat, and its activation has the potential to combat obesity and metabolic disorders. The company is working on developing a method to increase the amount of brown fat in the body, which could have significant therapeutic implications.
In addition to these programs, Biorestorative Therapies Inc. is also involved in the development of cell-based therapies for various other conditions like disc degeneration in the spine, metabolic disorders, and age-related muscle loss.
The company is actively engaged in research and development activities to advance its therapies through preclinical and clinical studies. Biorestorative Therapies Inc. works closely with leading scientists, researchers, and medical institutions to further its understanding and application of regenerative medicine.
Furthermore, the company has a strong commitment to regulatory compliance and ensures that its therapies are developed and tested in accordance with the highest safety and quality standards. Biorestorative Therapies Inc. aims to obtain regulatory approvals for its therapies and eventually make them available to patients worldwide.
Overall, Biorestorative Therapies Inc. is a biotechnology company dedicated to the development of innovative cell-based therapies to address a wide range of medical conditions. With a focus on regenerative medicine, the company aims to restore function and improve the quality of life for patients through the use of advanced stem cell technologies.
Biorestorative Therapies Inc. is a biotechnology company that focuses on developing and commercializing regenerative medicine solutions. The company primarily aims to address unmet medical needs in various therapeutic areas, particularly those related to tissue repair, regeneration, and biological healing. Below are extensive descriptions of the key segments, products, and services that Biorestorative Therapies Inc. offers.
Segments
1. Regenerative Medicine
- Biorestorative Therapies operates within the regenerative medicine segment, focusing on therapies that aim to restore the function of damaged or diseased tissues and organs. This includes the development of cell-based therapies and other biologically-derived products that harness the body’s natural healing processes.
2. Clinical Research and Development
- The company invests in R&D to innovate and improve its therapeutic offerings. This segment involves preclinical and clinical trials essential for obtaining regulatory approvals and ensuring the safety and efficacy of their products.
3. Manufacturing and Quality Control
- Biorestorative Therapies maintains a strict manufacturing process for its products, adhering to Good Manufacturing Practice (GMP) regulations. This segment encompasses the production of cellular therapies and biologics, which require high-quality standards to ensure patient safety.
Products
1. Cell-Based Therapies
- The company develops various cell-based therapies that utilize stem cells and other progenitor cells to promote tissue regeneration. These therapies are intended for applications such as orthopedic repair, pain management, and other conditions related to musculoskeletal health.
2. Biologics
- Biorestorative Therapies produces biologic materials derived from natural biological processes. These may include growth factors, extracellular matrices, and scaffold materials that support tissue regeneration.
3. Therapeutic Devices
- The company may also work on therapeutic devices that integrate their biological products, providing a combination of technology and biology to enhance healing outcomes. These devices often facilitate the delivery of cell therapies or biologics directly to the site of tissue injury.
4. Preclinical and Clinical Trial Products
- As part of their R&D arm, Biorestorative Therapies also develops specialized products for use in clinical trials. These products are designed to gather empirical data regarding the efficacy and safety of the company’s therapies.
Services
1. Regulatory Support
- Biorestorative Therapies offers guidance and support throughout the regulatory process, helping to navigate the challenges associated with obtaining the necessary approvals from health authorities. This includes preparing for Investigational New Drug (IND) applications and working toward successful product commercialization.
2. Clinical Trial Management
- The company may engage in services related to the design and management of clinical trials. This includes patient recruitment, site selection, data monitoring, and ensuring compliance with regulatory standards.
3. Custom Research and Product Development
- Biorestorative Therapies may offer collaboration opportunities for custom research and development projects. This could involve partnering with academic institutions or other organizations to leverage their expertise in regenerative medicine.
4. Consultation Services
- In addition to product offerings, Biorestorative Therapies might provide consultation services to healthcare providers and researchers in the field of regenerative medicine, including best practices for the application of their therapies.
Conclusion
Biorestorative Therapies Inc. is positioned at the forefront of regenerative medicine, creating innovative products and therapies aimed at enhancing healing and recovery. Its diverse segments, encompassing R&D, manufacturing, and clinical services, highlight its commitment to addressing the medical needs of patients through cutting-edge biological therapies. The company strives for continuous improvement and adherence to high standards to ensure the success of its regenerative treatments in the medical community.
Segments
1. Regenerative Medicine
- Biorestorative Therapies operates within the regenerative medicine segment, focusing on therapies that aim to restore the function of damaged or diseased tissues and organs. This includes the development of cell-based therapies and other biologically-derived products that harness the body’s natural healing processes.
2. Clinical Research and Development
- The company invests in R&D to innovate and improve its therapeutic offerings. This segment involves preclinical and clinical trials essential for obtaining regulatory approvals and ensuring the safety and efficacy of their products.
3. Manufacturing and Quality Control
- Biorestorative Therapies maintains a strict manufacturing process for its products, adhering to Good Manufacturing Practice (GMP) regulations. This segment encompasses the production of cellular therapies and biologics, which require high-quality standards to ensure patient safety.
Products
1. Cell-Based Therapies
- The company develops various cell-based therapies that utilize stem cells and other progenitor cells to promote tissue regeneration. These therapies are intended for applications such as orthopedic repair, pain management, and other conditions related to musculoskeletal health.
2. Biologics
- Biorestorative Therapies produces biologic materials derived from natural biological processes. These may include growth factors, extracellular matrices, and scaffold materials that support tissue regeneration.
3. Therapeutic Devices
- The company may also work on therapeutic devices that integrate their biological products, providing a combination of technology and biology to enhance healing outcomes. These devices often facilitate the delivery of cell therapies or biologics directly to the site of tissue injury.
4. Preclinical and Clinical Trial Products
- As part of their R&D arm, Biorestorative Therapies also develops specialized products for use in clinical trials. These products are designed to gather empirical data regarding the efficacy and safety of the company’s therapies.
Services
1. Regulatory Support
- Biorestorative Therapies offers guidance and support throughout the regulatory process, helping to navigate the challenges associated with obtaining the necessary approvals from health authorities. This includes preparing for Investigational New Drug (IND) applications and working toward successful product commercialization.
2. Clinical Trial Management
- The company may engage in services related to the design and management of clinical trials. This includes patient recruitment, site selection, data monitoring, and ensuring compliance with regulatory standards.
3. Custom Research and Product Development
- Biorestorative Therapies may offer collaboration opportunities for custom research and development projects. This could involve partnering with academic institutions or other organizations to leverage their expertise in regenerative medicine.
4. Consultation Services
- In addition to product offerings, Biorestorative Therapies might provide consultation services to healthcare providers and researchers in the field of regenerative medicine, including best practices for the application of their therapies.
Conclusion
Biorestorative Therapies Inc. is positioned at the forefront of regenerative medicine, creating innovative products and therapies aimed at enhancing healing and recovery. Its diverse segments, encompassing R&D, manufacturing, and clinical services, highlight its commitment to addressing the medical needs of patients through cutting-edge biological therapies. The company strives for continuous improvement and adherence to high standards to ensure the success of its regenerative treatments in the medical community.